GPC4 has been shown to be highly expressed in NPCs and in APOE4-carrying post-mortem AD brains, as such, the increase in NPCs observed at early-stage AD may contribute to the progression of AD through ApoE4 mediated tau hyperphosphorylation in high risk ApoE4 carriers [93,94]. The gene discussed is GPC4; the disease is Alzheimer disease.